ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
127 hedge funds and large institutions have $205M invested in Antares Pharma, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $1.89M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
127
Holding in Top 10
2
Calls
$1.63M
Puts
$1.89M
Top Buyers
| 1 | +$3.41M | |
| 2 | +$3.27M | |
| 3 | +$2.25M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.68M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$906K |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$5.07M | |
| 3 | -$3.83M | |
| 4 |
BC
Broadfin Capital
New York
|
-$2.96M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.25M |